What is Intramed Plus?
Intramed Plus operates as a specialized provider of intravenous infusion services, bridging the gap between clinical hospital settings and patient-centric home care. With a legacy spanning over three decades, the firm has cultivated a reputation for delivering personalized, safe, and cost-effective infusion therapies. Their dual-channel approach—offering both home-based infusion training and support alongside modern, comfortable infusion centers—positions them as a critical player in the regional healthcare ecosystem. By focusing on individual patient needs and maintaining high standards of clinical excellence, Intramed Plus has become a trusted partner for both patients and referring healthcare providers, effectively navigating the complexities of modern medical service delivery.
How much funding has Intramed Plus raised?
Intramed Plus has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Intramed Plus
PPP
Public-Private Partnership
What's next for Intramed Plus?
With this major strategic investment, Intramed Plus is entering a critical phase of enterprise-level scaling. The capital will likely be deployed to modernize existing infusion center infrastructure and expand the reach of their home-based care programs. As the demand for outpatient infusion services continues to rise, the company is well-positioned to capture additional market share by optimizing its supply chain and investing in advanced clinical training. Future growth trajectories will likely focus on integrating digital health solutions to streamline patient monitoring and improve therapeutic outcomes, ensuring that Intramed Plus remains at the forefront of the infusion therapy market while maintaining its commitment to affordable, high-quality care.
See full Intramed Plus company page
